717 related articles for article (PubMed ID: 12771128)
21. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function.
Seebach J; Mädler HJ; Wojciak-Stothard B; Schnittler HJ
Thromb Haemost; 2005 Sep; 94(3):620-9. PubMed ID: 16268481
[TBL] [Abstract][Full Text] [Related]
23. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling.
Zanetti A; Lampugnani MG; Balconi G; Breviario F; Corada M; Lanfrancone L; Dejana E
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):617-22. PubMed ID: 11950700
[TBL] [Abstract][Full Text] [Related]
25. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
26. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
27. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
28. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation?
Ilan N; Tucker A; Madri JA
Lab Invest; 2003 Aug; 83(8):1105-15. PubMed ID: 12920240
[TBL] [Abstract][Full Text] [Related]
30. Loss of density-dependent growth inhibition and dissociation of alpha-catenin from E-cadherin.
Tsukatani Y; Suzuki K; Takahashi K
J Cell Physiol; 1997 Oct; 173(1):54-63. PubMed ID: 9326449
[TBL] [Abstract][Full Text] [Related]
31. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro.
Lewalle JM; Bajou K; Desreux J; Mareel M; Dejana E; Noël A; Foidart JM
Exp Cell Res; 1997 Dec; 237(2):347-56. PubMed ID: 9434630
[TBL] [Abstract][Full Text] [Related]
32. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Tang FY; Nguyen N; Meydani M
Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
[TBL] [Abstract][Full Text] [Related]
33. Turn-off, drop-out: functional state switching of cadherins.
Lilien J; Balsamo J; Arregui C; Xu G
Dev Dyn; 2002 May; 224(1):18-29. PubMed ID: 11984870
[TBL] [Abstract][Full Text] [Related]
34. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
35. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
36. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.
Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D
EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928
[TBL] [Abstract][Full Text] [Related]
37. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
[TBL] [Abstract][Full Text] [Related]
38. The role of protein tyrosine phosphorylation in the cell-cell interactions, junctional permeability and cell cycle control in post-confluent bovine corneal endothelial cells.
Chen WL; Lin CT; Lo HF; Lee JW; Tu IH; Hu FR
Exp Eye Res; 2007 Aug; 85(2):259-69. PubMed ID: 17624326
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the expression of VE-cadherin/catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis.
Cai J; Jiang WG; Mansel RE
Biochem Biophys Res Commun; 1999 Apr; 258(1):113-8. PubMed ID: 10222244
[TBL] [Abstract][Full Text] [Related]
40. VEGF differentially activates STAT3 in microvascular endothelial cells.
Bartoli M; Platt D; Lemtalsi T; Gu X; Brooks SE; Marrero MB; Caldwell RB
FASEB J; 2003 Aug; 17(11):1562-4. PubMed ID: 12824281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
